DBV Technologies - Aktienkurs

Aktienkurs
8.41
Täglich Wechseln
-0.36 -4.10%
Monatlich
-5.51%
Jährlich
1,279.59%
Q2 Prognose
8.31

Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 21.98 0.43 2.00% 44.61% 2025-05-23
Alnylam Pharmaceuticals 289.96 0.96 0.33% 96.24% 2025-05-23
Amarin 11.11 0.12 1.09% 1,210.91% 2025-05-23
BioMarin Pharmaceutical 57.55 -0.46 -0.79% -23.80% 2025-05-23
DBV Technologies 8.41 -0.36 -4.10% 1,279.59% 2025-05-23
Halozyme Therapeutics 54.54 0.79 1.47% 24.46% 2025-05-23
Incyte 64.25 -0.27 -0.41% 12.09% 2025-05-23
Insmed 67.53 1.37 2.07% 206.95% 2025-05-23
Ionis Pharmaceuticals 32.98 -0.28 -0.84% -11.53% 2025-05-23
Neurocrine Biosciences 120.18 1.06 0.89% -13.79% 2025-05-23
PTC Therapeutics 45.93 0.41 0.90% 23.47% 2025-05-23
Ultragenyx Pharmaceutical 35.66 0.15 0.42% -11.60% 2025-05-23
Sarepta Therapeutics 37.90 -0.89 -2.29% -69.30% 2025-05-23
United Therapeutics 307.65 -1.07 -0.35% 12.74% 2025-05-23

Preis Tag Jahr Datum
USND 18737 -188.53 -1.00% 10.73% 2025-05-23